Abstract
Although many patients with hepatobiliary cancers are diagnosed at an advanced stage, all patients should be evaluated for treatment. Nevertheless, careful patient selection for treatment and active multidisciplinary cooperation are essential. Very few high-quality randomized clinical trials of patients with hepatobiliary cancers exist, and patient participation in prospective clinical trials is the preferred option for treatment of patients with all stages of disease.
Original language | English |
---|---|
Journal | JNCCN Journal of the National Comprehensive Cancer Network |
Volume | 7 |
Issue number | 4 |
Publication status | Published - Apr 2009 |
Externally published | Yes |
Keywords
- Biologic therapy
- Chemoembolization
- Chemotherapy
- Cholangiocarcinomas
- Cirrhosis
- Gallbladder cancer
- Hepatitis
- Hepatocellular carcinoma
- NCCN Clinical practice Guidelines
- Surgical resection
- Transplantation
- Tumor ablation
ASJC Scopus subject areas
- Oncology